The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
Open accessAbstract
Antimicrobial resistance is an old and silent pandemic. Resistant organisms emerge in parallel with new antibiotics, leading to a major global public health crisis over time. Antibiotic resistance may be due to different mechanisms and against different classes of drugs. These mechanisms are usually found in the same organism, giving rise to multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria. One resistance mechanism that is closely associated with the emergence of MDR and XDR bacteria is the efflux of drugs since the same pump can transport different classes of drugs. In Gram-negative bacteria, efflux pumps are present in two configurations: a transmembrane protein anchored in the inner membrane and a complex formed by three proteins. The tripartite complex has a transmembrane protein present in the inner membrane, a periplasmic protein, and a porin associated with the outer membrane. In Pseudomonas aeruginosa, one of the main pathogens associated with respiratory tract infections, four main sets of efflux pumps have been associated with antibiotic resistance: MexAB-OprM, MexXY, MexCD-OprJ, and MexEF-OprN. In this review, the function, structure, and regulation of these efflux pumps in P. aeruginosa and their actions as resistance mechanisms are discussed. Finally, a brief discussion on the potential of efflux pumps in P. aeruginosa as a target for new drugs is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intrinsic resistance in most strains arises from low outer membrane permeability, the production of enzymes that inactivate antimicrobials such as the AmpC β-lactamase, and antimicrobial efflux pumps139,147,149.”
From Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility (2025) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396
CARD 2020: Antibiotic Resistome Surveillance with the Comprehensive Antibiotic Resistance Database
Alcock, B. P., Raphenya, A. R., Lau, T. T. Y., Tsang, K. K., Bouchard, M., Edalatmand, A., Huynh, W., Nguyen, A.-L. V., Cheng, A. A., Liu, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz935 · Cited by 3,202
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
The TetR Family of Transcriptional Repressors
Ramos, J. L., Martínez-Bueno, M., Molina-Henares, A. J., Terán, W., Watanabe, K., Zhang, X., Gallegos, M. T., Brennan, R., & Tobes, R. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.326-356.2005 · Cited by 1,103
WHO PUBLISHES LIST OF BACTERIA FOR WHICH NEW ANTIBIOTICS ARE URGENTLY NEEDED
City, P. S. M. M. (2017) · Cited by 1,071
Multidrug efflux pumps: structure, function and regulation
Du, D., Wang-Kan, X., Neuberger, A., van Veen, H. W., Pos, K. M., Piddock, L. J. V., & Luisi, B. F. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0048-6 · Cited by 1,055
Winsor, G. L., Griffiths, E. J., Lo, R., Dhillon, B. K., Shay, J. A., & Brinkman, F. S. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1227 · Cited by 1,050
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Mechanisms of Solvent Tolerance in Gram-Negative Bacteria
Ramos, J. L., Duque, E., Gallegos, M.-T., Godoy, P., Ramos-González, M. I., Rojas, A., Terán, W., & Segura, A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161038 · Cited by 791
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Chromosomal genetics of Pseudomonas
Holloway, B. W., Krishnapillai, V., & Morgan, A. F. (1979) · Microbiological Reviews · doi:10.1128/mmbr.43.1.73-102.1979 · Cited by 761
Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations
Sun, J., Deng, Z., & Yan, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.05.090 · Cited by 746
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
Poole, K., Krebes, K., McNally, C., & Neshat, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7363-7372.1993 · Cited by 688
Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli
Nishino, K., & Yamaguchi, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.20.5803-5812.2001 · Cited by 666
Genetic Recombination in Pseudomonas aeruginosa
HOLLOWAY, B. W. (1955) · Microbiology · doi:10.1099/00221287-13-3-572 · Cited by 650
Active Efflux and Diffusion Are Involved in Transport of Pseudomonas aeruginosa Cell-to-Cell Signals
Pearson, J. P., Van Delden, C., & Iglewski, B. H. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1203-1210.1999 · Cited by 631
The multifaceted roles of antibiotics and antibiotic resistance in nature
Sengupta, S., Chattopadhyay, M. K., & Grossart, H.-P. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00047 · Cited by 629
McMurry, L., Petrucci, R. E., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 604
The pyocins of Pseudomonas aeruginosa
Michel-Briand, Y., & Baysse, C. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01422-0 · Cited by 560
Ko¨hler, T., Michéa‐Hamzehpour, M., Henze, U., Gotoh, N., Kocjancic Curty, L., & Pechère, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
Bacterial efflux pump inhibitors from natural sources
Stavri, M., Piddock, L. J. V., & Gibbons, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl460 · Cited by 547
Duan, K., Dammel, C., Stein, J., Rabin, H., & Surette, M. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03803.x · Cited by 509
Role of bacterial efflux pumps in biofilm formation
Alav, I., Sutton, J. M., & Rahman, K. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky042 · Cited by 504
Active efflux mechanisms for antimicrobial resistance
Levy, S. B. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.695 · Cited by 503
Antibiotic Susceptibility Profiles of Escherichia coli Strains Lacking Multidrug Efflux Pump Genes
Sulavik, M. C., Houseweart, C., Cramer, C., Jiwani, N., Murgolo, N., Greene, J., DiDomenico, B., Shaw, K. J., Miller, G. H., Hare, R., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1126-1136.2001 · Cited by 497
Molecular cloning and characterization of acrA and acrE genes of Escherichia coli
Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H., & Hearst, J. E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.19.6299-6313.1993 · Cited by 466
Diggle, S. P., & Whiteley, M. (2020) · Microbiology · doi:10.1099/mic.0.000860 · Cited by 459
Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Lambert, M.-L., Suetens, C., Savey, A., Palomar, M., Hiesmayr, M., Morales, I., Agodi, A., Frank, U., Mertens, K., Schumacher, M., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70258-9 · Cited by 443
Structure, function and regulation of Pseudomonas aeruginosa porins
Chevalier, S., Bouffartigues, E., Bodilis, J., Maillot, O., Lesouhaitier, O., Feuilloley, M. G. J., Orange, N., Dufour, A., & Cornelis, P. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux020 · Cited by 423
Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review
Tuon, F. F., Dantas, L. R., Suss, P. H., & Tasca Ribeiro, V. S. (2022) · Pathogens · doi:10.3390/pathogens11030300 · Cited by 422
Self-citationIto, A., Sato, T., Ota, M., Takemura, M., Nishikawa, T., Toba, S., Kohira, N., Miyagawa, S., Ishibashi, N., Matsumoto, S., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-17 · Cited by 400
Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics
Zhang, L., & Mah, T.-F. (2008) · Journal of Bacteriology · doi:10.1128/jb.01655-07 · Cited by 385
Saier, M. H., Tam, R., Reizer, A., & Reizer, J. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00362.x · Cited by 371
Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation
Kvist, M., Hancock, V., & Klemm, P. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.01310-08 · Cited by 353
The environmental occurrence of Pseudomonas aeruginosa
Crone, S., Vives‐Flórez, M., Kvich, L., Saunders, A. M., Malone, M., Nicolaisen, M. H., Martínez‐García, E., Rojas‐Acosta, C., Catalina Gomez‐Puerto, M., Calum, H., et al. (2020) · APMIS · doi:10.1111/apm.13010 · Cited by 340
Pagès, J.-M., & Amaral, L. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.12.011 · Cited by 329
Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E., & Bianco, N. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2021 · Cited by 324
Pier, G. B., Grout, M., & Zaidi, T. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12088 · Cited by 323
Elkins, C. A., & Nikaido, H. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6490-6499.2002 · Cited by 303
Köhler, T., Epp, S. F., Curty, L. K., & Pechère, J.-C. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.20.6300-6305.1999 · Cited by 302
De Kievit, T. R., Parkins, M. D., Gillis, R. J., Srikumar, R., Ceri, H., Poole, K., Iglewski, B. H., & Storey, D. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1761-1770.2001 · Cited by 294
Lv, L., Wan, M., Wang, C., Gao, X., Yang, Q., Partridge, S. R., Wang, Y., Zong, Z., Doi, Y., Shen, J., et al. (2020) · mBio · doi:10.1128/mbio.02930-19 · Cited by 288
RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition
Venter, H., Mowla, R., Ohene-Agyei, T., & Ma, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00377 · Cited by 285
Complete Genome Sequence of the Multiresistant Taxonomic Outlier Pseudomonas aeruginosa PA7
Roy, P. H., Tetu, S. G., Larouche, A., Elbourne, L., Tremblay, S., Ren, Q., Dodson, R., Harkins, D., Shay, R., Watkins, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008842 · Cited by 284
Efflux pumps and drug resistance in Gram-negative bacteria
Ma, D., Cook, D. N., Hearst, J. E., & Nikaido, H. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90654-8 · Cited by 282
Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Why big pharma has abandoned antibiotics
Plackett, B. (2020) · Nature · doi:10.1038/d41586-020-02884-3 · Cited by 278
Ziha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J.-C., & Plesiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump
Wang, Z., Fan, G., Hryc, C. F., Blaza, J. N., Serysheva, I. I., Schmid, M. F., Chiu, W., Luisi, B. F., & Du, D. (2017) · eLife · doi:10.7554/elife.24905 · Cited by 275
Expression in Escherichia coli of a New Multidrug Efflux Pump, MexXY, from Pseudomonas aeruginosa
Mine, T., Morita, Y., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.415 · Cited by 274
Structure of a cation-bound multidrug and toxic compound extrusion transporter
He, X., Szewczyk, P., Karyakin, A., Evin, M., Hong, W.-X., Zhang, Q., & Chang, G. (2010) · Nature · doi:10.1038/nature09408 · Cited by 272
Evolutionary origins of multidrug and drug‐specific efflux pumps in bacteria
Saier, M. H., Paulsen, I. T., Marek, K. S., Pao, S. S., Ronald, A. S., & Nikaido, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.03.265 · Cited by 263
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Genome Organization in Pseudomonas
Holloway, B. W., & Morgan, A. F. (1986) · Annual Review of Microbiology · doi:10.1146/annurev.mi.40.100186.000455 · Cited by 239
Chuanchuen, R., Narasaki, C. T., & Schweizer, H. P. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.18.5036-5044.2002 · Cited by 228
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 214
Tripartite assembly of RND multidrug efflux pumps
Daury, L., Orange, F., Taveau, J.-C., Verchère, A., Monlezun, L., Gounou, C., Marreddy, R. K. R., Picard, M., Broutin, I., Pos, K. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms10731 · Cited by 213
Aendekerk, S., Ghysels, B., Cornelis, P., & Baysse, C. (2002) · Microbiology · doi:10.1099/00221287-148-8-2371 · Cited by 212
Fitness of in vitro selected Pseudomonas aeruginosanalB and nfxB multidrug resistant mutants
Sanchez, P. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf185 · Cited by 209
Waite, R. D., Papakonstantinopoulou, A., Littler, E., & Curtis, M. A. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.18.6571-6576.2005 · Cited by 200
Schmalstieg, A. M., Srivastava, S., Belkaya, S., Deshpande, D., Meek, C., Leff, R., van Oers, N. S. C., & Gumbo, T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05546-11 · Cited by 195
Aínsa, J. A., Blokpoel, M. C. J., Otal, I., Young, D. B., De Smet, K. A. L., & Martín, C. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.22.5836-5843.1998 · Cited by 189
Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies
Yin, R., Cheng, J., Wang, J., Li, P., & Lin, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.955286 · Cited by 187
Srikumar, R., Kon, T., Gotoh, N., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.65 · Cited by 184
Bissonnette, L., Champetier, S., Buisson, J. P., & Roy, P. H. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.14.4493-4502.1991 · Cited by 182
Johnson, J. M., & Church, G. M. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2630 · Cited by 179
Sobel, M. L., Neshat, S., & Poole, K. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.4.1246-1253.2005 · Cited by 176
Lamarche, M. G., & Déziel, É. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024310 · Cited by 173
Balasubramanian, D., Schneper, L. M., Merighi, M., Smith, R. S., Narasimhan, G., Lory, S., & Mathee, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034067 · Cited by 167
Sakhtah, H., Koyama, L., Zhang, Y., Morales, D. K., Fields, B. L., Price-Whelan, A., Hogan, D. A., Shepard, K., & Dietrich, L. E. P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600424113 · Cited by 167
β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects
Glen, K. A., & Lamont, I. L. (2021) · Pathogens · doi:10.3390/pathogens10121638 · Cited by 167
Fraud, S., Campigotto, A. J., Chen, Z., & Poole, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01072-08 · Cited by 166
Cao, L., Srikumar, R., & Poole, K. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04210.x · Cited by 159
Structural basis of RND-type multidrug exporters
Yamaguchi, A., Nakashima, R., & Sakurai, K. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00327 · Cited by 159
López-Causapé, C., Sommer, L. M., Cabot, G., Rubio, R., Ocampo-Sosa, A. A., Johansen, H. K., Figuerola, J., Cantón, R., Kidd, T. J., Molin, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05621-5 · Cited by 158
del Barrio-Tofiño, E., Zamorano, L., Cortés-Lara, S., López-Causapé, C., Sánchez-Diener, I., Cabot, G., Bou, G., Martínez-Martínez, L., Oliver, A., GEMARA-SEIMC/REIPI Pseudomonas study Group, et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz147 · Cited by 158
Mima, T., Joshi, S. M., Escalada, M. G., & Schweizer, H. P. (2007) · Journal of Bacteriology · doi:10.1128/jb.00850-07 · Cited by 153
RND Efflux Pumps in Gram-Negative Bacteria; Regulation, Structure and Role in Antibiotic Resistance
Colclough, A., Alav, I., Whittle, E. E., Pugh, H. L., Darby, E. M., Legood, S., McNeil, H. E., & Blair, J. M. A. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0235 · Cited by 152
A new member of the tripartite multidrug efflux pumps,MexVW-OprM, in Pseudomonas aeruginosa
Li, Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg390 · Cited by 151
Hassan, K. A., Liu, Q., Elbourne, L. D. H., Ahmad, I., Sharples, D. J., Naidu, V., Chan, C. L., Li, L., Harborne, S. P. D., Pokhrel, A., et al. (2018) · Research in Microbiology · doi:10.1016/j.resmic.2018.01.001 · Cited by 146
Bacteria-Host Crosstalk: Sensing of the Quorum in the Context of Pseudomonas aeruginosa Infections
Turkina, M. V., & Vikström, E. (2018) · Journal of Innate Immunity · doi:10.1159/000494069 · Cited by 146
Li, X.-Z., Poole, K., & Nikaido, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.27-33.2003 · Cited by 144
Maseda, H., Saito, K., Nakajima, A., & Nakae, T. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09367.x · Cited by 142
A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas
Cazares, A., Moore, M., Hall, J. P. J., Wright, L. L., Grimes, M., Emond-Rhéault, J.-G., Pongchaikul, P., Santanirand, P., Lévesque, R. C., Fothergill, J. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15081-7 · Cited by 142
What It Takes to Be a Pseudomonas aeruginosa? The Core Genome of the Opportunistic Pathogen Updated
Valot, B., Guyeux, C., Rolland, J. Y., Mazouzi, K., Bertrand, X., & Hocquet, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126468 · Cited by 141
Silva, P. E. A., Bigi, F., Santangelo, M. D. L. P., Romano, M. I., Martín, C., Cataldi, A. A., & Aínsa, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.800-804.2001 · Cited by 141
Kriengkauykiat, J., Porter, E. M., Lomovskaya, O., & Wong‐Beringer, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.565-570.2005 · Cited by 137
Jeannot, K., Elsen, S., Köhler, T., Attree, I., van Delden, C., & Plésiat, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01107-07 · Cited by 136
He, G.-X., Kuroda, T., Mima, T., Morita, Y., Mizushima, T., & Tsuchiya, T. (2003) · Journal of Bacteriology · doi:10.1128/jb.186.1.262-265.2004 · Cited by 136
Reza, A., Sutton, J. M., & Rahman, K. M. (2019) · Antibiotics · doi:10.3390/antibiotics8040229 · Cited by 135
Tsutsumi, K., Yonehara, R., Ishizaka-Ikeda, E., Miyazaki, N., Maeda, S., Iwasaki, K., Nakagawa, A., & Yamashita, E. (2019) · Nature Communications · doi:10.1038/s41467-019-09463-9 · Cited by 135
Fetar, H., Gilmour, C., Klinoski, R., Daigle, D. M., Dean, C. R., & Poole, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-10 · Cited by 134
The introduction of ‘chemotherapy’ using arsphenamine – the first magic bullet
Williams, K. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2009.09k036 · Cited by 132
Identification of Transport Proteins Involved in Free Fatty Acid Efflux in Escherichia coli
Lennen, R. M., Politz, M. G., Kruziki, M. A., & Pfleger, B. F. (2012) · Journal of Bacteriology · doi:10.1128/jb.01477-12 · Cited by 131
Lodge, J., Minchin, S., Piddock, L. J. V., & Busby, S. J. W. (1990) · Biochemical Journal · doi:10.1042/bj2720627 · Cited by 127
Mao, W., Warren, M. S., Black, D. S., Sato, T., Murata, T., Nishino, T., Gotoh, N., & Lomovskaya, O. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03223.x · Cited by 127
Recio, R., Mancheño‐Losa, M., Viedma, E., Villa, J., Orellana, M. Á., Lora‐Tamayo, J., & Cháves, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01759-19 · Cited by 126
Genomic mapping of Pseudomonas aeruginosa PAO
Holloway, B. W., Römling, U., & Tümmler, B. (1994) · Microbiology · doi:10.1099/13500872-140-11-2907 · Cited by 124
Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
Horna, G., López, M., Guerra, H., Sáenz, Y., & Ruiz, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-34694-z · Cited by 122
Bialvaei, A. Z., Rahbar, M., Hamidi-Farahani, R., Asgari, A., Esmailkhani, A., Mardani-Dashti, Y., & Soleiman-Meigooni, S. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104789 · Cited by 121
Colour Me Blue: The History and the Biotechnological Potential of Pyocyanin
Gonçalves, T. A., & Vasconcelos, U. (2021) · Molecules · doi:10.3390/molecules26040927 · Cited by 120
Intrinsic Antimicrobial Resistance Determinants in the Superbug Pseudomonas aeruginosa
Murray, J. L., Kwon, T., Marcotte, E. M., & Whiteley, M. (2015) · mBio · doi:10.1128/mbio.01603-15 · Cited by 119
Guénard, S., Muller, C., Monlezun, L., Benas, P., Broutin, I., Jeannot, K., & Plésiat, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01252-13 · Cited by 119
Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence
Rampioni, G., Pillai, C. R., Longo, F., Bondì, R., Baldelli, V., Messina, M., Imperi, F., Visca, P., & Leoni, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-11892-9 · Cited by 114
nalD Encodes a Second Repressor of the mexAB-oprM Multidrug Efflux Operon of Pseudomonas aeruginosa
Morita, Y., Cao, L., Gould, V. C., et al. (2006) · Journal of Bacteriology · doi:10.1128/jb.01342-06 · Cited by 111
Piddock, L. J. V., Garvey, M. I., Rahman, M. M., & Gibbons, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq079 · Cited by 111
A physical genome map of Pseudomonas aeruginosa PAO.
Römling, U., Grothues, D., Bautsch, W., & Tümmler, B. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08592.x · Cited by 110
Piddock, L. J. V., Williams, K. J., & Ricci, V. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.2.159 · Cited by 109
Morita, Y., Komori, Y., Mima, T., Kuroda, T., Mizushima, T., & Tsuchiya, T. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10794.x · Cited by 108
Gotoh, N., Tsujimoto, H., Tsuda, M., Okamoto, K., Nomura, A., Wada, T., Nakahashi, M., & Nishino, T. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1938 · Cited by 107
Stokes, H. W., & Hall, R. M. (1991) · Plasmid · doi:10.1016/0147-619x(91)90032-r · Cited by 97
Dong, N., Zeng, Y., Wang, Y., Liu, C., Lu, J., Cai, C., Liu, X., Chen, Y., Wu, Y., Fang, Y., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00221-x · Cited by 96
Mechanisms of Pyocyanin Toxicity and Genetic Determinants of Resistance in Staphylococcus aureus
Noto, M. J., Burns, W. J., Beavers, W. N., & Skaar, E. P. (2017) · Journal of Bacteriology · doi:10.1128/jb.00221-17 · Cited by 94
Mima, T., Sekiya, H., Mizushima, T., Kuroda, T., & Tsuchiya, T. (2005) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2005.tb03696.x · Cited by 82
Prasanna Vadhana, A., Singh, B. R., Pesingi, P. K., Bhardwaj, M., Singh, S. V., Kumawat, M., Sinha, D. K., & Gandham, R. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02664 · Cited by 81
Sanz‐García, F., Gil‐Gil, T., Laborda, P., Ochoa-Sánchez, L. E., Martínez, J. L., & Hernando‐Amado, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158080 · Cited by 79
Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa
Hirakata, Y., Kondo, A., Hoshino, K., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.06.007 · Cited by 77
mvaTmutation modifies the expression of thePseudomonas aeruginosamultidrug efflux operonmexEF-oprN
Westfall, L. W., Carty, N. L., Layland, N., Kuan, P. J., Colmer‐Hamood, J. A., & Hamood, A. N. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2005.00075.x · Cited by 77
Sekiya, H., Mima, T., Morita, Y., Kuroda, T., Mizushima, T., & Tsuchiya, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2990-2992.2003 · Cited by 77
Issa, K. H. B., Phan, G., & Broutin, I. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00057 · Cited by 74
Structure and dynamics of the drug-bound bacterial transporter EmrE in lipid bilayers
Shcherbakov, A. A., Hisao, G. S., Mandala, V. S., Thomas, N. E., Soltani, M., Salter, E. A., Davis, J. H., Henzler‐Wildman, K. A., & Hong, M. (2021) · Nature Communications · doi:10.1038/s41467-020-20468-7 · Cited by 74
Morita, Y., Tomida, J., & Kawamura, Y. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00008 · Cited by 72
Richardot, C., Juarez, P., Jeannot, K., Patry, I., Plésiat, P., & Llanes, C. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02622-15 · Cited by 72
Hay, T. J. M., Fraud, S., Lau, C. H., Gilmour, C., & Poole, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056858 · Cited by 71
López-Causapé, C., Rubio, R., Cabot, G., & Oliver, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02583-17 · Cited by 69
Molecular mechanisms of polymyxin resistance and detection of mcr genes
Mlynárčik, P., & Kolář, M. (2018) · Biomedical Papers · doi:10.5507/bp.2018.070 · Cited by 69
Poudyal, B., & Sauer, K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01981-17 · Cited by 68
Early appropriate diagnostics and treatment of MDR Gram-negative infections
Bassetti, M., Kanj, S. S., Kiratisin, P., Rodrigues, C. S., van Duin, D., Villegas, M. V., & Yu, Y. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac089 · Cited by 67
Shigemura, K., Osawa, K., Kato, A., Tokimatsu, I., Arakawa, S., Shirakawa, T., & Fujisawa, M. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.34 · Cited by 66
Morita, Y., Tomida, J., & Kawamura, Y. (2012) · Microbiology · doi:10.1099/mic.0.054320-0 · Cited by 64
Functional Analysis of Novel Multidrug Transporters from Human Pathogens
Ninio, S., Rotem, D., & Schuldiner, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108231200 · Cited by 63
Cryo-EM structure of multidrug efflux pump MexAB-OprM (0 degree state)
Tsutsumi, K., Yonehara, R., Nakagawa, A., & Yamashita, E. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6iok/pdb · Cited by 63
Bioinformatics Approaches to the Understanding of Molecular Mechanisms in Antimicrobial Resistance
Camp, P.-J. V., Haslam, D. B., & Porollo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041363 · Cited by 62
Boutoille, D., Corvec, S., Caroff, N., Giraudeau, C., Espaze, E., Caillon, J., Plésiat, P., & Reynaud, A. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00882-6 · Cited by 60
Al-Hamad, A., Upton, M., & Burnie, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp271 · Cited by 60
Tambat, R., Mahey, N., Chandal, N., Verma, D. K., Jangra, M., Thakur, K. G., & Nandanwar, H. S. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00281 · Cited by 60
Adamson, D. H., Krikstopaityte, V., & Coote, P. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv111 · Cited by 54
Saier, M. H. (1996) · Microbial & Comparative Genomics · doi:10.1089/mcg.1996.1.129 · Cited by 52
Dynamics of Intact MexAB-OprM Efflux Pump: Focusing on the MexA-OprM Interface
López, C. A., Travers, T. S., Pos, K. M., Zgurskaya, H. I., & Gnanakaran, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-16497-w · Cited by 52
Assembly and regulation of the chlorhexidine-specific efflux pump AceI
Bolla, J. R., Howes, A. C., Fiorentino, F., & Robinson, C. V. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003271117 · Cited by 51
Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa
Mehla, J., Malloci, G., Mansbach, R. A., López, C. A., Tsivkovski, R., Haynes, K. M., Leus, I. V., Grindstaff, S. B., Cascella, R. H., D’Cunha, N., et al. (2021) · mBio · doi:10.1128/mbio.02785-20 · Cited by 49
Vidal-Aroca, F., Meng, A., Minz, T., Page, M. G. P., & Dreier, J. (2009) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2009.09.021 · Cited by 47
Jolly, A. L., Takawira, D., Oke, O. O., Whiteside, S. A., Chang, S. W., Wen, E. R., Quach, K., Evans, D. J., & Fleiszig, S. M. J. (2015) · mBio · doi:10.1128/mbio.02533-14 · Cited by 46
Dawan, J., Li, Y., Lü, F., He, X., & Ahn, J. (2022) · Pathogens · doi:10.3390/pathogens11020147 · Cited by 46
Mitchell, C. J., Stone, T. A., & Deber, C. M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00730-19 · Cited by 45
Singh, M. K., Yau, Y. C. W., Wang, S. V., Waters, V. J., & Kumar, A. (2017) · Canadian Journal of Microbiology · doi:10.1139/cjm-2017-0380 · Cited by 44
Aguilar-Rodea, P., Zúñiga, G., Cerritos, R., Rodríguez-Espino, B. A., Gomez-Ramirez, U., Nolasco-Romero, C. G., López-Marceliano, B., Rodea, G. E., Mendoza-Elizalde, S., Reyes‐López, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266742 · Cited by 40
Kaatz, G. W. (2002) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.7.2.223 · Cited by 38
Figueroa-Romero, A., Pons‐Duran, C., & González, R. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7080152 · Cited by 38
A PhoPQ-Regulated ABC Transporter System Exports Tetracycline in Pseudomonas aeruginosa
Chen, L., & Duan, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02986-15 · Cited by 36
Zwama, M., Yamaguchi, A., & Nishino, K. (2019) · Communications Biology · doi:10.1038/s42003-019-0564-6 · Cited by 36
McDaniel, C. T., Su, S., Panmanee, W., Lau, G. W., Browne, T., Cox, K., Paul, A. T., Ko, S.-H. B., Mortensen, J. E., Lam, J. S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00291 · Cited by 33
Stress Introduction Rate Alters the Benefit of AcrAB-TolC Efflux Pumps
Langevin, A. M., & Dunlop, M. J. (2017) · Journal of Bacteriology · doi:10.1128/jb.00525-17 · Cited by 33
Garratt, I., Aranega-Bou, P., Sutton, J. M., Moore, G., & Wand, M. E. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.00210-21 · Cited by 31
Adamiak, J. W., Jhawar, V., Bonifay, V., Chandler, C. E., Leus, I. V., Ernst, R. K., Schweizer, H. P., & Zgurskaya, H. I. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00592-21 · Cited by 31
Ranjitkar, S., Jones, A. K., Mostafavi, M., Zwirko, Z., Iartchouk, O., Barnes, S. W., Walker, J. R., Willis, T. W., Lee, P. S., & Dean, C. R. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01718-18 · Cited by 28
Yero, D., Díaz‐Lobo, M., Costenaro, L., Conchillo‐Solé, O., Mayo, A., Ferrer‐Navarro, M., Vilaseca, M., Gibert, I., & Daura, X. (2021) · Communications Biology · doi:10.1038/s42003-021-01968-8 · Cited by 28
Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods
Laudy, A. E. (2018) · Polish Journal of Microbiology · doi:10.21307/pjm-2018-017 · Cited by 26
Laborda, P., Alcalde‐Rico, M., Chini, A., Martínez, J. L., & Hernando‐Amado, S. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15511 · Cited by 26
Pseudomonas aeruginosa adapts to octenidine via a combination of efflux and membrane remodelling
Bock, L. J., Ferguson, P. M., Clarke, M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02566-4 · Cited by 26
Stubenrauch, C. J., Bamert, R. S., Wang, J., & Lithgow, T. J. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001523 · Cited by 24
Kawałek, A., Modrzejewska, M., Zieniuk, B., Bartosik, A. A., & Jagura‐Burdzy, G. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01199-19 · Cited by 22
Amieva, R., Gil‐Gil, T., Martínez, J. L., & Alcalde‐Rico, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147492 · Cited by 22
Yuan, L., Zhai, Y.-J., Wu, H., Sun, H., He, Z.-P., Wang, Y., Pan, Y., Kuang, N.-N., & Hu, G. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000736 · Cited by 18
Sabrin, A., Gioe, B. W., Gupta, A., & Grove, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006638 · Cited by 18
Assembly and Functional Role of PACE Transporter PA2880 from Pseudomonas aeruginosa
Zhao, J., Hellwig, N., Djahanschiri, B., Khera, R. A., Morgner, N., Ebersberger, I., Wang, J., & Michel, H. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01453-21 · Cited by 18
Dulyayangkul, P., Satapoomin, N., Avison, M. B., Charoenlap, N., Vattanaviboon, P., & Mongkolsuk, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.592153 · Cited by 14
Iftikhar, A., Asif, A., Manzoor, A., Azeem, M., Sarwar, G., Rashid, N., & Qaisar, U. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104491 · Cited by 13
de Oliveira, W. K., Ferrarini, M. G., Morello, L. G., & Faoro, H. (2020) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa055 · Cited by 12
Self-citationSpatial Characteristics of the Efflux Pump MexB Determine Inhibitor Binding
Yamasaki, S., Koga, N., Zwama, M., Sakurai, K., Nakashima, R., Yamaguchi, A., & Nishino, K. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00672-22 · Cited by 10
Nag, A., & Mehra, S. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11837-x · Cited by 6
Cited by
Mechanisms of antimicrobial resistance in biofilms
Liu, H. Y., Prentice, E. L., & Webber, M. A. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00046-3 · Cited by 545
Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
Evaluation of Antibiotic Resistance Mechanisms in Gram-Negative Bacteria
Gauba, A., & Rahman, K. M. (2023) · Antibiotics · doi:10.3390/antibiotics12111590 · Cited by 255
Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility
Letizia, M., Diggle, S. P., & Whiteley, M. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01193-8 · Cited by 231
Verdial, C., Serrano, I., Tavares, L., Gil, S., & Oliveira, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041221 · Cited by 71
Metadata
- Authors
- Lorusso, A. B., Carrara, J. A., Barroso, C. D. N., Tuon, F. F., & Faoro, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-12-13
- Volume
- 23
- Issue
- 24
- Pages
- 15779
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4312138773
- Cited by
- 347
- References
- 181
- FWCI
- 16.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.